ETON — Eton Pharmaceuticals Cashflow Statement
0.000.00%
Last trade - 00:00- $424.25m
- $439.13m
- $39.01m
- 29
- 15
- 83
- 37
Annual cashflow statement for Eton Pharmaceuticals, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -28 | -1.96 | -9.02 | -0.936 | -3.82 |
| Depreciation | |||||
| Non-Cash Items | 3.96 | 2.98 | 4.34 | 3.25 | 4.34 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.01 | -6.21 | 7.72 | 3.6 | -0.698 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -22.3 | -4.72 | 4.82 | 6.82 | 0.969 |
| Capital Expenditures | -0.05 | -3.26 | -2.79 | -0.775 | -10 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0.7 | 0 | 0 | -30 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.05 | -2.56 | -2.79 | -0.775 | -40 |
| Financing Cash Flow Items | — | — | — | — | 0.248 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 31.6 | 0.391 | -0.134 | -0.957 | 32.6 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 9.23 | -6.89 | 1.9 | 5.08 | -6.45 |